18
Uro-Oncology Sites in Network
A clinical research technology partner of sponsors and sites, Third Opinion AI-enables and analyzes site EHR data to maximize patient enrollment. Third Opinion processes unstructured notes, documents, and media files the EHR can't query — surfacing every trial-eligible patient alongside the site, with physician oversight at every step.
Urology & Oncology Technology Partner
Uro-Oncology Sites in Network
Patients Covered
Sponsor Trials Run
Disease States Covered — NMIBC · mCRPC · UTUC · UTI
Across the clinical trial industry, patient enrollment is the bottleneck:
Third Opinion exists to change those numbers — without adding work for your staff.
Surfacing trial-ready candidates hidden in unstructured EHR notes, documents, and media that structured queries can't reach.
Matching patients against inclusion and exclusion criteria in days, not months — compressing your path to full enrollment.
AI-enabled chart review with physician oversight at every step — and zero workflow change for your clinical staff.
An NMIBC trial example: how Third Opinion narrows a typical large urology practice's population to a short list of candidates worth a site's time.
STARTING POPULATION
Total patients at a typical large urology group practice
▼ 0.5% · STRUCTURED EHR FILTER
NMIBC-potential patients identified in the last 12 months
▼ 2.3% · UNSTRUCTURED DATA AI
Pathology-confirmed CIS cases in the last 90 days
▼ 8.6% · FULL CRITERIA MATCH
Patients meet all criteria and go to the site for review
Figures are illustrative and reflect a representative site; individual practice results will vary.
One platform, two partners — each motivated to rapidly identify trial-eligible patients.
Accelerate your uro-oncology trial with a network of 18+ activation-ready urology sites covering ~8M patients. Identify eligible patients your EHR can't surface, and shorten your path to full enrollment.
Grow clinical research revenue without changing your workflow. Third Opinion AI-enables your EHR, surfaces trial-ready patients, and helps you onboard more sponsor trials.
